ClinicalTrials.gg
Drug

Solriamfetol clinical trials

Also written JZP-110 and Sunosi.

studies test it
29
open now
7
in phase 3
13
first study started
2011

How each study uses solriamfetol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the solriamfetol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
20 Mar 2019 · SUNOSI · NDA 211230 (FDA, Drugs@FDA)
European Union
16 Jan 2020 · Sunosi · EMEA/H/C/004893 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Solriamfetol
11
Solriamfetol 150 mg
5
Solriamfetol 300 mg
4
Solriamfetol 75 MG
2
ADX-N05
2

Brand

Sunosi
5
Sunosi 75 mg
1
Sunosi 150 mg
1

Development codes

JZP-110
7

Studies by the year they started

28 studies that test it; most in 2024 (7)

Studies that test solriamfetol, by start year
YearStudies
20111
20121
20154
20162
20171
20216
20233
20247
20251
20262

Who runs them

Industry 20 · Other 9

Axsome Therapeutics, Inc. (9) · Jazz Pharmaceuticals (9) · Duke University (2) · University of Pennsylvania (1) · Rochester Center for Behavioral Medicine (1) · Ignis Therapeutics (Suzhou) Limited (1) · Massachusetts General Hospital (1) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1)

Often tested with

Tested in the same studies.

Modafinil (2) · Melatonin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4, 2 in phase 3

Studies that test solriamfetol, phase 3 first.

Studies

Open first, then newest update. How each study uses solriamfetol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 29

See all 29 studies that test solriamfetol →

Codes

What other systems call solriamfetol · ClinicalTrials.gg INT000800

  • MeSH (NLM) C000623308solriamfetolConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 939U7C91AISOLRIAMFETOLConfirmed FDA, NLM, Wikidata
  • RxNorm 2121751Confirmed FDA, Wikidata
  • Wikidata Q39059979solriamfetolConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152389SolriamfetolOne source FDA
  • DrugBank DB14754One source Wikidata

Also registered as solriamfetol hydrochloride (UNII K7RO88SP7A · RxNorm 2121750).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.